欣天科技(300615.SZ):擬向奇林實業增資225萬元
格隆匯5月18日丨欣天科技(300615.SZ)公佈,2023年5月12日,經深圳市欣天科技股份有限公司總經理辦公會審議通過,同意公司與深圳市奇林實業有限公司(簡稱“奇林實業”)簽訂《增資協議》,公司使用自有資金向奇林實業增資225萬元(其中人民幣26.32萬元認購奇林實業新增註冊資本26.32萬元,人民幣198.68萬元計入奇林實業資本公積)。本次增資完成後,公司將持有奇林實業5%的股權。該協議已於2023年5月16日,在深圳市南山區完成簽署。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.